[HTML][HTML] Pharmacokinetics–pharmacodynamics issues relevant for the clinical use of beta-lactam antibiotics in critically ill patients

RP Veiga, JA Paiva - Critical Care, 2018 - Springer
Antimicrobials are among the most important and commonly prescribed drugs in the
management of critically ill patients and beta-lactams are the most common antibiotic class …

A guide to therapeutic drug monitoring of β‐lactam antibiotics

AJ Fratoni, DP Nicolau, JL Kuti - Pharmacotherapy: The Journal …, 2021 - Wiley Online Library
Therapeutic drug monitoring (TDM) opens the door to personalized medicine, yet it is
infrequently applied to β‐lactam antibiotics, one of the most commonly prescribed drug …

Interaction of obesity and infections

NV Dhurandhar, D Bailey, D Thomas - Obesity reviews, 2015 - Wiley Online Library
There is evidence that certain infections may induce obesity. Obese persons may also have
more severe infections and have compromised response to therapies. The objective of this …

Comprehensive guidance for antibiotic dosing in obese adults

L Meng, E Mui, MK Holubar… - … : The Journal of Human …, 2017 - Wiley Online Library
Physiologic alterations seen in obesity commonly impact the pharmacokinetics (PK) and
pharmacodynamics (PD) of antibiotics and may result in suboptimal dosing in this …

Therapeutic drug monitoring-based dose optimisation of piperacillin and meropenem: a randomised controlled trial

JJ De Waele, S Carrette, M Carlier, V Stove… - Intensive care …, 2014 - Springer
Purpose There is variability in the pharmacokinetics (PK) of antibiotics (AB) in critically ill
patients. Therapeutic drug monitoring (TDM) could overcome this variability and increase PK …

[HTML][HTML] Advances in antibiotic therapy in the critically ill

JL Vincent, M Bassetti, B François, G Karam, J Chastre… - Critical Care, 2016 - Springer
Infections occur frequently in critically ill patients and their management can be challenging
for various reasons, including delayed diagnosis, difficulties identifying causative …

Risk factors for target non-attainment during empirical treatment with β-lactam antibiotics in critically ill patients

JJ De Waele, J Lipman, M Akova, M Bassetti… - Intensive care …, 2014 - Springer
Purpose Risk factors for β-lactam antibiotic underdosing in critically ill patients have not
been described in large-scale studies. The objective of this study was to describe …

Meropenem use and therapeutic drug monitoring in clinical practice: a literature review

NA Steffens, ES Zimmermann… - Journal of clinical …, 2021 - Wiley Online Library
What is known and objective Meropenem, a carbapenem antibiotic, is widely prescribed for
the treatment of life‐threatening infections. The main parameter associated with its …

Effect of obesity on the pharmacokinetics of antimicrobials in critically ill patients: a structured review

AS Alobaid, M Hites, J Lipman, FS Taccone… - International journal of …, 2016 - Elsevier
The increased prevalence of obesity presents challenges for clinicians aiming to provide
optimised antimicrobial dosing in the intensive care unit. Obesity is likely to exacerbate the …

[HTML][HTML] Rationale and evidence for the use of new beta-lactam/beta-lactamase inhibitor combinations and cefiderocol in critically ill patients

F Barbier, S Hraiech, S Kernéis, N Veluppillai… - Annals of Intensive …, 2023 - Springer
Background Healthcare-associated infections involving Gram-negative bacteria (GNB) with
difficult-to-treat resistance (DTR) phenotype are associated with impaired patient-centered …